SEC Form D · Amendment · filed August 3, 2023
Luminary Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (23)
James Haymaker · Minneapolis, MNDirectorJohn Hurley · Minneapolis, MNExecTracey Lodie · Minneapolis, MNDirectorMark Chance · Minneapolis, MNDirectorJeff Liter · Minneapolis, MNExec · Director · PromoterJohn Wells · Minneapolis, MNDirectorDavid Largaespada · Minneapolis, MNDirector · PromoterC. R. Carter · Atlanta, GADirectorBenjamin A. Lincoln · Santa Monica, CADirectorRobert O'Sullivan · West Palm Beach, FLDirector · PromoterChristopher J. Kocourek · MINNEAPOLIS, MNExecMichael Falk · West Palm Beach, FLDirectorJason Gelberd · West Palm Beach, FLDirectorDouglas E. Mark · MINNEAPOLIS, MNExec · Director · PromoterAlexander Naydich · Minneapolis, MNDirectorMichael Aceti · Needham, MADirectorDean Eliott · Needham, MADirectorJoseph Arboleda-Valasquez · Needham, MAExecSteven J. Speck, Ii · BOWLING GREEN, OHExec · Director · PromoterJosh Harris · New York, NYDirector · PromoterEvan Zemsky · New York, NYDirectorMark S. Feldman · Dallas, TXDirectorAlexander Naydich · Minneapolis, MNDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗